Posted by Michael Wonder on 22 Jul 2021
Novartis aims to beat rivals to novel $10 billion cancer treatment market
22 July 2021 - Trial results for new targeted therapy ‘pretty remarkable’, says CEO.
Novartis is hoping to cement an early lead in a potential $10 billion market for a new type of cancer treatment, called novel radioligand therapy, after positive results from its trials.
